{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T02:40:12Z","timestamp":1700361612249},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (KAKENHI) grant","award":["JP 20K18261"],"award-info":[{"award-number":["JP 20K18261"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The background is that intravenous adrenaline administration is recommended for advanced cardiovascular life support in adults and endotracheal administration is given low priority. The reason is that the optimal dose of adrenaline in endotracheal administration is unknown, and it is ethically difficult to design studies of endotracheal adrenaline administration with non-cardiopulmonary arrest. We otolaryngologists think so because we administered adrenaline to the vocal folds for hemostasis after intracordal injection under local anesthesia, but have had few cases of vital changes. We hypothesized that examining vital signs before and after adrenaline administration for hemostasis would help determine the optimal dose of endotracheal adrenaline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively examined the medical records of 79 patients who visited our hospital from January 2018 to December 2020 and received adrenaline in the vocal folds and trachea for hemostasis by intracordal injection under local anesthesia to investigate changes in heart rate and systolic blood pressure before and after the injection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean heart rates before and after injection were 83.96\u2009\u00b1\u200918.51 (standard deviation) beats per minute (bpm) and 81.50\u2009\u00b1\u200915.38 (standard deviation) bpm, respectively. The mean systolic blood pressure before and after the injection were 138.13\u2009\u00b1\u200925.33 (standard deviation) mmHg and 135.72\u2009\u00b1\u200922.19 (standard deviation) mmHg, respectively. Heart rate and systolic blood pressure had <jats:italic>P<\/jats:italic>-values of 0.136, and 0.450, respectively, indicating no significant differences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although this study was an observational, changes in vital signs were investigated assuming endotracheal adrenaline administration. The current recommended dose of adrenaline in endotracheal administration with cardiopulmonary arrest may not be effective. In some cases of cardiopulmonary arrest, intravenous and intraosseous routes of adrenaline administration may be difficult and the opportunity for resuscitation may be missed. Therefore, it is desirable to have many options for adrenaline administration. Therefore, if the optimal dose and efficacy of endotracheal adrenaline administration can be clarified, early adrenaline administration will be possible, which will improve return of spontaneous circulation (ROSC) and survival discharge rates.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-023-02376-1","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T13:01:42Z","timestamp":1696597302000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in vital signs during adrenaline administration for hemostasis in intracordal injection: an observational study with a hypothetical design of endotracheal adrenaline administration in cardiopulmonary arrest"],"prefix":"10.1186","volume":"18","author":[{"given":"Tomohiro","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"2376_CR1","unstructured":"JRC Resuscitation Guidelines 2020 Japan Resuscitation Council [https:\/\/www.jrc-cpr.org\/?s=JRC+Resuscitation+Guidelines+2020+#]"},{"key":"2376_CR2","doi-asserted-by":"publisher","first-page":"S444","DOI":"10.1161\/CIR.0000000000000261","volume":"132","author":"MS Link","year":"2015","unstructured":"Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: adult advanced cardiovascular life support: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132:S444\u201364.","journal-title":"Circulation"},{"key":"2376_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.resuscitation.2015.07.016","volume":"95","author":"J Soar","year":"2015","unstructured":"Soar J, Nolan JP, B\u00f6ttiger BW, et al. European resuscitation council guidelines for resuscitation 2015: section 3. Adult advanced life support. Resuscitation. 2015;95:100\u201347.","journal-title":"Resuscitation"},{"key":"2376_CR4","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/00003246-200006000-00022","volume":"28","author":"JT Niemann","year":"2000","unstructured":"Niemann JT, Stratton SJ. Endotracheal versus intravenous epinephrine and atropine in out-of-hospital \u201cprimary\u201d and postcountershock asystole. Crit Care Med. 2000;28:1815\u20139.","journal-title":"Crit Care Med"},{"key":"2376_CR5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S0140-6736(87)91608-4","volume":"1","author":"DN Quinton","year":"1987","unstructured":"Quinton DN, O\u2019Byrne G, Aitkenhead AR. Comparison of endotracheal and peripheral intravenous adrenaline in cardiac arrest. Is the endotracheal route reliable? Lancet. 1987;1:828\u20139.","journal-title":"Lancet"},{"key":"2376_CR6","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.ajem.2019.02.035","volume":"37","author":"JM Burgert","year":"2019","unstructured":"Burgert JM, Johnson AD, O\u2019Sullivan JC, et al. Pharmacokinetic effects of endotracheal, intraosseous, and intravenous epinephrine in a swine model of traumatic cardiac arrest. Am J Emerg Med. 2019;37:2043\u201350.","journal-title":"Am J Emerg Med"},{"key":"2376_CR7","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/lary.29200","volume":"131","author":"S Hirano","year":"2021","unstructured":"Hirano S, Sugiyama Y, Kaneko M, et al. Intracordal injection of basic fibroblast growth factor in 100 cases of vocal fold atrophy and scar. Laryngoscope. 2021;131:2059\u201364.","journal-title":"Laryngoscope"},{"key":"2376_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/00016489.2017.1314550","volume":"137","author":"T Kanazawa","year":"2017","unstructured":"Kanazawa T, Kurakami K, Kashima K, et al. Injection of basic fibroblast growth factor for unilateral vocal cord paralysis. Acta Otolaryngol. 2017;137:962\u20137.","journal-title":"Acta Otolaryngol"},{"key":"2376_CR9","doi-asserted-by":"publisher","first-page":"E338","DOI":"10.1002\/lary.25315","volume":"125","author":"T Kanazawa","year":"2015","unstructured":"Kanazawa T, Komazawa D, Indo K, et al. Single injection of basic fibroblast growth factor to treat severe vocal fold lesions and vocal fold paralysis. Laryngoscope. 2015;125:E338\u201344.","journal-title":"Laryngoscope"},{"key":"2376_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1213\/00000539-196703000-00033","volume":"46","author":"JS Redding","year":"1967","unstructured":"Redding JS, Asuncion JS, Pearson JW. Effective routes of drug administration during cardiac arrest. Anesth Analg. 1967;46:253\u20138.","journal-title":"Anesth Analg"},{"key":"2376_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0361-1124(79)80036-2","volume":"8","author":"JR Roberts","year":"1979","unstructured":"Roberts JR, Greenberg MI, Knaub MA, et al. Blood levels following intravenous and endotracheal epinephrine administration. JACEP. 1979;8:53\u20136.","journal-title":"JACEP"},{"issue":"11","key":"2376_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/00016489.2021.1995895","volume":"141","author":"S Takahashi","year":"2021","unstructured":"Takahashi S, Kanazawa T, Hasegawa T, et al. Comparison of therapeutic effects of steroid injection by benign vocal fold lesion type. Acta Otolaryngol. 2021;141(11):1005\u201313.","journal-title":"Acta Otolaryngol"},{"key":"2376_CR13","first-page":"4060","volume":"6","author":"M Presta","year":"1986","unstructured":"Presta M, Moscatelli D, Joseph-Silverstein J, et al. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol. 1986;6:4060\u20136.","journal-title":"Mol Cell Biol"},{"key":"2376_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1210\/edrv-8-2-95","volume":"8","author":"D Gospodarowicz","year":"1987","unstructured":"Gospodarowicz D, Ferrara N, Schweigerer L, et al. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987;8:95\u2013114.","journal-title":"Endocr Rev"},{"key":"2376_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1083\/jcb.105.2.957","volume":"105","author":"O Saksela","year":"1987","unstructured":"Saksela O, Moscatelli D, Rifkin DB. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol. 1987;105:957\u201363.","journal-title":"J Cell Biol"},{"key":"2376_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1126\/science.2432664","volume":"235","author":"J Folkman","year":"1987","unstructured":"Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442\u20137.","journal-title":"Science"},{"key":"2376_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1083\/jcb.109.1.1","volume":"109","author":"DB Rifkin","year":"1989","unstructured":"Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol. 1989;109:1\u20136.","journal-title":"J Cell Biol"},{"key":"2376_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1","volume":"181","author":"SM Sheehan","year":"1999","unstructured":"Sheehan SM, Allen RE. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol. 1999;181:499\u2013506.","journal-title":"J Cell Physiol"},{"key":"2376_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1089\/107632702760240526","volume":"8","author":"Y Kimura","year":"2002","unstructured":"Kimura Y, Ozeki M, Inamoto T, et al. Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng. 2002;8:603\u201313.","journal-title":"Tissue Eng"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02376-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T02:23:59Z","timestamp":1700360639000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-023-02376-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2376"],"URL":"https:\/\/doi.org\/10.1186\/s13019-023-02376-1","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We received approval from the Ethics Committee in our hospital with approval number.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}